Rollins Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,730
Closed -$250K 136
2024
Q4
$250K Buy
1,730
+2
+0.1% +$310 0.04% 114
2024
Q3
$280K Sell
1,728
-407
-19% -$64.8K 0.05% 106
2024
Q2
$312K Sell
2,135
-1,108
-34% -$165K 0.05% 99
2024
Q1
$513K Sell
3,243
-198
-6% -$31.5K 0.1% 69
2023
Q4
$539K Buy
+3,441
New +$528K 0.11% 64

Other funds holding JNJ

Rollins Financial Advisors's JNJ Position: Q1 2025 in Review

Rollins Financial Advisors sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 1,730 shares — an estimated $250K sold.

Rollins Financial Advisors first reported a position in JNJ in Q4 2023 and held it in 5 quarters. The position peaked at $539K in Q4 2023. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Rollins Financial Advisors reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Rollins Financial Advisors sold 1,730 Johnson & Johnson shares in Q1 2025, an estimated $250K.
  • Rollins Financial Advisors first reported a position in Johnson & Johnson in Q4 2023 and held it in 5 quarters.
  • Rollins Financial Advisors's Johnson & Johnson position peaked at $539K in Q4 2023.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Rollins Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.